AFG
IHE icon

Arkansas Financial Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Arkansas Financial Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Buy
23,489
+14,478
+161% +$1.3M 0.3% 45
2026
Q1 		$791K Buy
9,011
+1,876
+26% +$164K 0.11% 60
2025
Q4 		$605K Sell
7,135
-280
-4% -$22.3K 0.09% 63
2025
Q3 		$538K Buy
7,415
+702
+10% +$48.4K 0.08% 64
2025
Q2 		$440K Hold
6,713
– – 0.07% 64
2025
Q1 		$409K Sell
6,713
-210
-3% -$14.6K 0.07% 64
2024
Q4 		$455K Sell
6,923
-1,746
-20% -$120K 0.07% 63
2024
Q3 		$612K Buy
8,669
+3,454
+66% +$241K 0.1% 56
2024
Q2 		$346K Buy
+5,215
New +$342K 0.06% 61
2022
Q1 		– Sell
-3,081
Closed -$205K – 48
2021
Q4 		$205K Buy
+3,081
New +$195K 0.04% 47
2021
Q3 		– Sell
-3,270
Closed -$202K – 44
2021
Q2 		$202K Buy
+3,270
New +$199K 0.05% 45
2018
Q4 		– Sell
-3,588
Closed -$200K – 27
2018
Q3 		$200K Buy
+3,588
New +$196K 0.08% 24
2017
Q4 		– Sell
-3,882
Closed -$202K – 24
2017
Q3 		$202K Hold
3,882
– – 0.09% 22
2017
Q2 		$201K Buy
+3,882
New +$196K 0.09% 21
2016
Q1 		– Sell
-3,882
Closed -$209K – 22
2015
Q4 		$209K Buy
+3,882
New +$204K 0.13% 20
2015
Q3 		– Sell
-3,882
Closed -$226K – 21
2015
Q2 		$226K Sell
3,882
-390
-9% -$22.8K 0.14% 19
2015
Q1 		$246K Buy
4,272
+390
+10% +$21.3K 0.15% 20
2014
Q4 		$196K Sell
3,882
-1,215
-24% -$59.2K 0.12% 19
2014
Q3 		$238K Hold
5,097
– – 0.16% 19
2014
Q2 		$230K Sell
5,097
-402
-7% -$17.3K 0.16% 19
2014
Q1 		$232K Sell
5,499
-1,404
-20% -$58.9K 0.17% 19
2013
Q4 		$272K Buy
+6,903
New +$259K 0.21% 16

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BFA
Brendel Financial Advisors Hanover, New Hampshire $216M AUM 38.85% 1-Year Est. Return

Arkansas Financial Group's IHE Position: Q2 2026 in Review

Arkansas Financial Group increased its iShares US Pharmaceuticals ETF (IHE) stake by 161% in Q2 2026, buying an estimated $1.3M and bringing the position to 23,489 shares worth $2.33M. The position accounts for 0.3% of the portfolio, ranked #45.

Arkansas Financial Group first reported a position in IHE in Q4 2013 and has held it in 22 quarters since. 83 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Arkansas Financial Group held 23,489 shares of iShares US Pharmaceuticals ETF worth $2.33M as of Q2 2026.
  • Arkansas Financial Group bought 14,478 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $1.3M.
  • iShares US Pharmaceuticals ETF made up 0.3% of Arkansas Financial Group's portfolio in Q2 2026, its #45 holding.
  • Arkansas Financial Group first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and has held it in 22 quarters since.
  • 83 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Arkansas Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.